R&D COMMERCIALIZATION

"Businesses outside of healthcare are redefining the US$9.59 trillion global healthcare market for consumers, providers, payers, and investors in both developed and developing nations. Insightful and entrepreneurial leaders and organizations are bringing healthcare technologies, innovative organizations, affordable and convenient care options, disrupting longstanding standards in the industry. (Source: “Global healthcare’s new entrants” pwc.com)"

PWC’s spot-on analysis is a statement that rings so true today. More entrepreneurial and innovative organizations and leaders are disrupting the “business-as-usual” notion in the global healthcare industry.

However, the road to successful commercialization of new healthcare technologies can be fraught with mismatched partnerships, poor financial management and lack of market-ready knowhow.

TZ Core believes that innovative healthcare technologies deserve equally innovative management knowhow and financial prowess. There are no set formulas to commercialization. Past case studies cannot be replicated because the landscape and market opportunities have shifted. Commercialization needs to align with today’s relevance and timing.

Commercialization has to prioritize market-ready technology, market need, market potential with market-suited financial resources. And, as diverse as new healthcare technologies appear, so too must commercialization techniques and financial support be as innovative.

Welcome to TZ Healthcare Management, the epicenter for age-related technologies meet planned pathways to commercialization.

Connect with us to learn more